United States of America

Kimberly-Clark to Acquire Kenvue for $48.7B

Published NOV 4 2025

Story

Above: Tylenol for sale at a CVS Pharmacy in Austin, Texas, on Nov. 3, 2025. Image credit: Brandon Bell/Getty Images

The Facts

Kimberly-Clark announced on Monday that it had struck a deal to acquire Kenvue in a cash-and-stock transaction valued at $48.7 billion, bringing together brands like Huggies and Kleenex with Band-Aid and Tylenol under one consumer health giant.
Daily Caller
CNBC
Under the terms of the agreement, Kenvue shareholders will receive $3.50 per share in cash plus 0.14625 Kimberly-Clark shares for each Kenvue share held, averaging $21.01 per share based on Kimberly-Clark’s closing prices as of last Friday.
Kenvue
According to a joint press release, the combined company will generate approximately $32 billion in annual revenue and include 10 separate billion-dollar brands, with Kimberly-Clark shareholders owning 54% and Kenvue shareholders owning 46% of the merged entity.
Kenvue
The companies project the merger to make run-rate synergies of $2.1 billion, including $1.9 billion in cost savings expected within three years and $500 million in revenue synergies within four, partially offset by $300 million in reinvestment.
Kenvue
The takeover follows the departure of Kenvue's CEO in July, as well as guidance from the Trump administration in September regarding the use of Tylenol during pregnancy, which claimed a potential autism risk.
Independent
The Washington Examiner
Donald Trump
The transaction requires shareholder approval from both companies and regulatory clearance before the deal closes in the second half of 2026, with Kimberly-Clark Chairman and CEO Mike Hsu retaining his dual position in the combined company.
Kenvue

Sources Split

LEFT

CENTER

RIGHT

ESTAB
CRIT

CENTER

PRO
ESTAB

The Spin

Narrative A

This massive $48.7 billion acquisition is a dangerous gamble that doubles down on litigation risks and integration nightmares. Kimberly-Clark is inheriting Kenvue's talc lawsuits and Tylenol controversies while attempting an impossibly complex merger with minimal operational overlap. The projected $1.9 billion in cost savings is additionally wildly optimistic.

Bloomberg

Morning Star

Narrative B

This transformative deal will create a global health and wellness powerhouse, with 10 billion-dollar brands serving nearly half the world’s population. The merger delivers compelling financial benefits for shareholders and positions both companies to capitalize on secular growth trends in health and wellness, unlocking massive growth potential and litigation resources.

Kenvue